Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-22

Clinical Trial Update: Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses [Phase 4]

View source ↗

Summary

Clinical trial update on imiquimod 3.75% cream in combination with cryotherapy for hypertrophic actinic keratoses (actinic keratosis) in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod 3.75% Cream (Imiquimod)

Snippet

Sponsor: Frankel, Amylynne, M.D. | Conditions: Actinic Keratosis | Phase 4 | Status: UNKNOWN